Ainos, Inc. - Common Stock (AIMD)

SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 26, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it will implement a consolidation of its common stock ("stock consolidation"), effective at the opening of trading on June 30, 2025. This strategic action positions Ainos to attract broader institutional interest as it enters a commercial execution phase in the second half of 2025 and supports the Company's continued Nasdaq listing.

AI Nose and SLM SmellTech platform enter scale-up phase targeting robotics, automation, and environmental sensing markets

Ainos Hits Inflection Point with AI Nose Pilot Ramp in Senior Care, Robotics, and Semiconductors

AI Nose Platform Advances Toward Scaled Pilot Programs Across Healthcare, Robotics, and Industrials

AI Nose accuracy in elderly care improved to 85% with additional Smell ID training

Accelerating Toward Commercial Rollout as AI Nose Solves Critical Gaps in Elder Care

Harnessing AI-Powered Scent Digitization for Smarter, Safer, and More Sustainable Factories

Unveiled revolutionary AI Nose for robotics application, inviting global robotics companies to join Ainos Alliance in shaping the future of smell-enabled robots

Robotic Smell Intelligence Goes Live at Asia's Premier AI Tech Stage

Strategic media partnership will amplify AINOS's brand and innovation story across major financial networks and digital platforms

Early results show steroid-free remission, opening pathway into $13B global pet dental health market

412% revenue growth reflects AI Nose sales in elderly care

Q1 revenues increased 412% year over year, driven by AI Nose products

ORLANDO, FL / ACCESS Newswire / May 2, 2025 / RedChip Companies will air interviews with Atossa Therapeutics, Inc. (Nasdaq:ATOS) and Ainos, Inc. (Nasdaq:AIMD) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV this Saturday, May 3, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Practical partnership for AI Nose, multiple new opportunities

A Major Breakthrough in Ainos' Mission to Digitize Scent

Expanding AI Nose's Commercial Opportunity for Smarter, Safer, and More Sustainable Factories

Robotic smelltech by AI Nose moves from concept to integration in weeks

Milestone Ignites a New Era of Smell-Enabled Robotics

Dual Trials Accelerate VELDONA® Toward Rare Disease Market Entry

Strategic partnerships and industry-leading accuracy position Ainos as a game-changer in digitized scent technology

SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 24, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that it will participate in a fireside chat with Do Kim, senior research analyst of Water Tower Research ("WTR") and John Roy, managing director of WTR on Tuesday, April 8, 2025, at 10:00 a.m. ET.

Another key win in expanding AI Nose's industrial opportunities

Revolutionary Oral Interferon Technology Combines Unmatched Advantages and Global Potential in the $16 Billion Coronavirus Market

Report highlights greater visibility in AI Nose developments, including robotics, smart manufacturing, elderly care monitoring, and women's health testing